Measuring the Ability to Tolerate Activity-Related Discomfort: Initial Validation of the Physical Activity Acceptance Questionnaire (PAAQ)

J Phys Act Health. 2015 May;12(5):717-6. doi: 10.1123/jpah.2013-0338. Epub 2014 Aug 7.

Abstract

Background: Physical activity (PA) is essential for health, but many adults find PA adherence challenging. Acceptance of discomfort related to PA may influence an individual's ability to begin and sustain a program of exercise. The aim of this study was to evaluate the psychometric properties of the Physical Activity Acceptance Questionnaire (PAAQ).

Methods: The PAAQ was administered to 3 distinct samples (N = 418). Each sample completed additional self-report measures; 1 sample also wore accelerometers for 7 days (at baseline and 6 months later).

Results: The PAAQ demonstrated high internal validity for its total score (α = .89) and 2 subscales (Cognitive Acceptance α = .86, Behavioral Commitment α = .85). The PAAQ also showed convergent validity with measures of mindfulness, self-reported physical activity levels, and accelerometer-verified levels of moderate-to-vigorous PA (MVPA; P-values < .05). The Cognitive Acceptance subscale showed predictive validity for objectively-verified PA levels among individuals attempting to increase PA over 6 months (P = .05). Test-retest reliability for a subset of participants (n = 46) demonstrated high consistency over 1 week (P < .0001).

Conclusions: The PAAQ demonstrates sound psychometric properties, and shows promise for improving the current understanding of PA facilitators and barriers among adults.

Trial registration: ClinicalTrials.gov NCT01854320 NCT01858714.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Accelerometry / instrumentation*
  • Adult
  • Aged
  • Exercise / psychology*
  • Exercise Tolerance*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mindfulness
  • Predictive Value of Tests
  • Psychometrics / statistics & numerical data*
  • Reproducibility of Results
  • Self Report
  • Surveys and Questionnaires*

Associated data

  • ClinicalTrials.gov/NCT01854320
  • ClinicalTrials.gov/NCT01858714